Cargando…
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Anaplastic thyroid cancer (ATC) is a rare refractory disease, frequently associated with BRAF mutations and aberrant vascular endothelial growth factor (VEGF) secretion. The antitumor effects of sorafenib were evaluated, and its mechanisms of action were investigated. Four human ATC cell lines were...
Autores principales: | Ishihara, Sae, Onoda, Naoyoshi, Noda, Satoru, Asano, Yuka, Tauchi, Yukie, Morisaki, Tamami, Kashiwagi, Shinichiro, Takashima, Tsutomu, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776193/ https://www.ncbi.nlm.nih.gov/pubmed/31545405 http://dx.doi.org/10.3892/ijo.2019.4881 |
Ejemplares similares
-
Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study
por: Onoda, Naoyoshi, et al.
Publicado: (2019) -
Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017) -
Adenoid Cystic Carcinoma of the Breast: A Case Report
por: Kashiwagi, Shinichiro, et al.
Publicado: (2019) -
Partial mastectomy using manual blunt dissection (MBD) in early breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2015) -
Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
por: Asano, Yuka, et al.
Publicado: (2016)